U.K. Authorizes AstraZeneca Vaccine For Emergency Use

The Astra Zeneca and Oxford University vaccine is set to impact global vaccination efforts due to its affordability and ease of storage. Unlike other COVID vaccines, it doesn't require ultracold storage, making it more accessible. The UK plans to use its initial supply to vaccinate as many people as possible by administering the first dose widely, rather than reserving doses for a second shot. The rollout is expected to begin next week.

Which institutions are responsible for developing the AstraZeneca vaccine?

• Pfizer and BioNTech

• Moderna and NIH

• AstraZeneca and Oxford University

• Johnson & Johnson

What is a significant advantage of the AstraZeneca vaccine compared to others?

• It requires only one dose

• It is more effective

• It is cheaper and doesn't need ultracold storage

• It is available worldwide

How does the UK plan to use its initial supply of the AstraZeneca vaccine?

• To vaccinate only healthcare workers

• To give as many people as possible the first dose

• To reserve doses for the second shot

• To export to other countries

When is the UK planning to start administering the AstraZeneca vaccine?

• Next quarter

• Next month

• Next week

• Next year

What is the primary goal of the UK's vaccination strategy with the AstraZeneca vaccine?

• To ensure everyone gets two doses

• To focus on urban areas

• To vaccinate only the elderly

• To maximize the number of people receiving the first dose